1754 related articles for article (PubMed ID: 16224390)
21. Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.
Taketomi T; Szlam F; Bader SO; Sheppard CA; Levy JH; Tanaka KA
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):135-41. PubMed ID: 18277134
[TBL] [Abstract][Full Text] [Related]
22. Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII.
Liebman HA; Chediak J; Fink KI; Galvez AG; Shah PC; Sham RL
Am J Hematol; 2000 Mar; 63(3):109-13. PubMed ID: 10679799
[TBL] [Abstract][Full Text] [Related]
23. Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent.
Hedner U; Brun NC
Neuroradiology; 2007 Oct; 49(10):789-93. PubMed ID: 17653706
[TBL] [Abstract][Full Text] [Related]
24. Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.
Aljamali MN; Kjalke M; Hedner U; Ezban M; Tranholm M
Haemophilia; 2009 Nov; 15(6):1318-26. PubMed ID: 19659796
[TBL] [Abstract][Full Text] [Related]
25. Experiences with recombinant human factor VIIa in patients with thrombocytopenia.
Goodnough LT
Semin Hematol; 2004 Jan; 41(1 Suppl 1):25-9. PubMed ID: 14872417
[TBL] [Abstract][Full Text] [Related]
26. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
27. Factor VIIa and its potential therapeutic use in bleeding-associated pathologies.
Hedner U
Thromb Haemost; 2008 Oct; 100(4):557-62. PubMed ID: 18841276
[TBL] [Abstract][Full Text] [Related]
28. History of rFVIIa therapy.
Hedner U
Thromb Res; 2010 Apr; 125 Suppl 1():S4-6. PubMed ID: 20188400
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological concentrations of recombinant factor VIIa restore hemostasis independent of tissue factor in antibody-induced hemophilia mice.
Keshava S; Sundaram J; Rajulapati A; Pendurthi UR; Rao LV
J Thromb Haemost; 2016 Mar; 14(3):546-50. PubMed ID: 26727350
[TBL] [Abstract][Full Text] [Related]
30. Recombinant factor VIIa: a review on its clinical use.
Franchini M
Int J Hematol; 2006 Feb; 83(2):126-38. PubMed ID: 16513530
[TBL] [Abstract][Full Text] [Related]
31. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
Poon MC
Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145
[TBL] [Abstract][Full Text] [Related]
32. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
Hoffman M; Monroe DM
Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
[TBL] [Abstract][Full Text] [Related]
33. Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.
Antovic JP; Antovic A; He S; Tengborn L; Blombäck M
Haemophilia; 2002 Nov; 8(6):781-6. PubMed ID: 12410647
[TBL] [Abstract][Full Text] [Related]
34. Recombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical development.
Jurlander B; Thim L; Klausen NK; Persson E; Kjalke M; Rexen P; Jørgensen TB; Østergaard PB; Erhardtsen E; Bjørn SE
Semin Thromb Hemost; 2001 Aug; 27(4):373-84. PubMed ID: 11547359
[TBL] [Abstract][Full Text] [Related]
35. Further understanding of recombinant activated factor VII mode of action.
Monroe DM
Semin Hematol; 2008 Apr; 45(2 Suppl 1):S7-S11. PubMed ID: 18544430
[TBL] [Abstract][Full Text] [Related]
36. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U; Kenet G; Lubetski A; Luboshitz J; Segal E
Can J Anaesth; 2002 Dec; 49(10):S15-20. PubMed ID: 12546003
[TBL] [Abstract][Full Text] [Related]
37. First 20 years with recombinant FVIIa (NovoSeven).
Hedner U; Lee CA
Haemophilia; 2011 Jan; 17(1):e172-82. PubMed ID: 20609014
[TBL] [Abstract][Full Text] [Related]
38. The emerging role of recombinant-activated factor VII in neurocritical care.
Fewel ME; Park P
Neurocrit Care; 2004; 1(1):19-29. PubMed ID: 16174895
[TBL] [Abstract][Full Text] [Related]
39. The use of recombinant activated coagulation factor VII for spine surgery.
Weiskopf RB
Eur Spine J; 2004 Oct; 13 Suppl 1(Suppl 1):S83-8. PubMed ID: 15160317
[TBL] [Abstract][Full Text] [Related]
40. Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa.
Wegert W; Harder S; Bassus S; Kirchmaier CM
Platelets; 2005 Feb; 16(1):45-50. PubMed ID: 15763896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]